## Core Concept
SERMs, or **Selective Estrogen Receptor Modulators**, are a class of drugs that act on the estrogen receptor. They are used for various conditions, including the treatment of osteoporosis, by mimicking estrogen's beneficial effects on bone density. SERMs can have estrogen agonist or antagonist effects depending on the tissue.

## Why the Correct Answer is Right
Raloxifene is a second-generation SERM that has been shown to **increase bone mineral density** and reduce the risk of vertebral fractures in postmenopausal women, making it useful for the treatment of osteoporosis. It acts as an estrogen agonist in bone and lipid metabolism but as an antagonist in breast and uterine tissue, which helps in reducing the risk of breast cancer without increasing the risk of endometrial cancer.

## Why Each Wrong Option is Incorrect
* **Option A:** This option is blank and cannot be evaluated.
* **Option B:** This option is blank and cannot be evaluated.
* **Option D:** This option is blank and cannot be evaluated.

## Clinical Pearl / High-Yield Fact
A key point to remember is that SERMs like raloxifene can have **varying effects on different tissues**, which is why they are termed "selective." This selectivity is crucial for their therapeutic benefits and for minimizing side effects. For example, raloxifene's antagonist effect on breast tissue provides protection against breast cancer.

## Correct Answer Line
**Correct Answer: C. Raloxifene**.